Episode
Med Spa Legal Roundtable: Ghost Medical Directors, Compliance Pitfalls & Competitor Reports
- Podcast
- Med Spa Success Strategies
- Published
- Jun 5, 2026
- Duration seconds
- 2523
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/med-spa-success-strategies-6424829/episodes/med-spa-legal-roundtable-ghost-medical-directors-compliance-pitfalls-competitor-reports/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/med-spa-success-strategies-6424829/med-spa-legal-roundtable-ghost-medical-directors-compliance-pitfalls-competitor-reports.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to the Med Spa Success Strategies Podcast, presented by Ricky Shockley of Med Spa Magic Marketing. If you're ready to implement more efficient & effective marketing strategies for your practice, book your FREE strategy session & marketing plan: https://go.medspamagicmarketing.com/schedule Ready to simplify your med spa operations and grow smarter? Visit https://www.glossgenius.com/medspasuccessstrategies and use code STRATEGIES for 50% off of GlossGenius's Medspa & Aesthetic plans.In this episode of the Med Spa Success Strategies Podcast, Ricky sits down with healthcare attorneys and operators Sara Shikhman and Samara Bell of Lengea Law ( https://lengealaw.com/ ) to unpack the critical legal and compliance issues shaping the aesthetics industry today. From the hidden dangers of "ghost" medical directors and cheap compliance shortcuts to state-specific regulatory enforcement and the risks of research-use peptides, Sara and Samara bring both elite legal expertise and real-world operator perspectives to help you protect and scale your practice. In this episode, we cover:✅ The reality of regulatory threats, undercover audits, and compliance pitfalls.✅ Moving past the "ghost" medical director model and establishing real supervision.✅ Recommended compliance baselines: chart auditing cadences and in-person visits.✅ How competitor reports and disgruntled ex-employees trigger board investigations.✅ The July 1st New York NP independent practice authority cliffhanger.✅ Recent medical and pharmacy board compliance updates in Indiana and Georgia.✅ Sourcing GLP-1s safely: third-party testing, pharmacy verification, and the risk of forged papers.✅ The massive legal liability of using "research use only" labeled peptides.✅ A new wave…